BIO-GATE
BIO-GATE operates in Diversified Metals & Mining.
BIO-GATE (BIG1) - Total Assets
Latest total assets as of December 2023: €5.26 Million EUR
Based on the latest financial reports, BIO-GATE (BIG1) holds total assets worth €5.26 Million EUR as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BIO-GATE - Total Assets Trend (2016–2023)
This chart illustrates how BIO-GATE’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BIO-GATE - Asset Composition Analysis
Current Asset Composition (December 2023)
BIO-GATE's total assets of €5.26 Million consist of 64.0% current assets and 36.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 25.2% |
| Accounts Receivable | €338.27K | 6.4% |
| Inventory | €1.24 Million | 23.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.15 Million | 21.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how BIO-GATE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BIO-GATE's current assets represent 64.0% of total assets in 2023, an increase from 53.5% in 2016.
- Cash Position: Cash and equivalents constituted 25.2% of total assets in 2023, down from 30.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 26.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 23.6% of total assets.
BIO-GATE Competitors by Total Assets
Key competitors of BIO-GATE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
BIO-GATE - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BIO-GATE generates 1.38x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BIO-GATE is currently not profitable relative to its asset base.
BIO-GATE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.48 | 3.54 | 1.93 |
| Quick Ratio | 2.20 | 1.99 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.40 Million | € 3.02 Million | € 905.08K |
BIO-GATE - Advanced Valuation Insights
This section examines the relationship between BIO-GATE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -15.4% |
| Total Assets | €5.26 Million |
| Market Capitalization | $5.37K USD |
Valuation Analysis
Below Book Valuation: The market values BIO-GATE's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BIO-GATE's assets decreased by 15.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BIO-GATE (2016–2023)
The table below shows the annual total assets of BIO-GATE from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €5.26 Million | -15.44% |
| 2022-12-31 | €6.22 Million | +19.31% |
| 2021-12-31 | €5.21 Million | +57.46% |
| 2020-12-31 | €3.31 Million | +5.89% |
| 2019-12-31 | €3.13 Million | +5.80% |
| 2018-12-31 | €2.95 Million | -25.54% |
| 2017-12-31 | €3.97 Million | +58.77% |
| 2016-12-31 | €2.50 Million | -- |